studies, and HRQoL research.Develop asset value assessments and economic value frameworks to support pricing, reimbursement, and access decisions.Shape and communicate compelling economic value stories for assigned assets and indications.Influence clinical development programs to ensure evidence generation plans address HTA and payer requirements, including evolving EU HTA needs.Contribute to global value dossiers and support affiliates in the development of robust market access and reimbursement strategies.Partner with cross-functional teams to deliver evidence generation initiatives such as patient preference studies, natural history studies, and other outcomes research programs.Provide HEOR expertise and guidance throughout the product lifecycle, helping translate evidence into successful access outcomes.Contribute to scientific publications, congress presentations, abstracts, posters, and external scientific engagement activities.Support innovation and continuous improvement by sharing best practices, methodologies, and emerging approaches across the HEOR community. For this role we're looking for:Master's degree or PhD in Health Economics, Outcomes Research, Market Access, Public Health, Epidemiology, Pharmacy, or a related discipline.Strong experience within HEOR, Market Access, Outcomes Research, or Health Economics in the pharmaceutical, biotechnology, or consulting sectors.Expertise in health economic modelling, cost-effectiveness analyses, budget impact modelling, and outcomes research methodologies.Experience supporting HTA submissions, reimbursement processes, and payer evidence requirements across multiple markets.Rare Disease experience is highly desirable.Experience working across regions or at a global/intercontinental level, with a strong understanding of diverse healthcare systems and payer environments. clinical and economic value of UCB's therapies.This role offers a unique opportunity to influence development programs from early stages through commercialization, helping ensure that innovative therapies achieve successful patient access around the world.Who You'll Work WithYou will work closely with colleagues across Health Economics
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK) employer: UCB S.A.
UCB S.A. is an exceptional employer that fosters a collaborative and innovative work culture, particularly in the field of immunology. With a strong commitment to employee growth and development, you will have access to unique opportunities for professional advancement while working in a hybrid environment that promotes work-life balance. Join us in making a meaningful impact on patient outcomes across the UK and Ireland, where your contributions will be valued and recognised.
